As shown by He et al. sulindac sulfide (200 μM) and indomethacin (400 μM) can bind and repress PPARδ transcriptional activity in HCT116 and SW480 human colon cancer cells (92). The gene discussed is PPARD; the disease is colonic neoplasm.